Tesla (TSLA) Stock Declined While Light Street Capital Management Cut Holding; Princeton Portfolio Strategies Group Cut Its Cvs Health (CVS) Holding as Share Value Declined

April 17, 2018 - By Winifred Garcia

CVS Health Corporation (NYSE:CVS) Logo

Glen Kacher decreased its stake in Tesla Inc (TSLA) by 42.31% based on its latest 2017Q4 regulatory filing with the SEC. Light Street Capital Management Llc sold 55,000 shares as the company’s stock declined 14.15% with the market. The hedge fund run by Glen Kacher held 75,000 shares of the capital goods company at the end of 2017Q4, valued at $23.35M, down from 130,000 at the end of the previous reported quarter. Light Street Capital Management Llc who had been investing in Tesla Inc for a number of months, seems to be less bullish one the $49.00 billion market cap company. The stock decreased 0.39% or $1.13 during the last trading session, reaching $290.08. About 5.22M shares traded. Tesla, Inc. (NASDAQ:TSLA) has risen 3.32% since April 17, 2017 and is uptrending. It has underperformed by 8.23% the S&P500.

Princeton Portfolio Strategies Group Llc decreased its stake in Cvs Health (CVS) by 34.08% based on its latest 2017Q4 regulatory filing with the SEC. Princeton Portfolio Strategies Group Llc sold 9,851 shares as the company’s stock declined 17.45% with the market. The institutional investor held 19,055 shares of the medical and nursing services company at the end of 2017Q4, valued at $1.38 million, down from 28,906 at the end of the previous reported quarter. Princeton Portfolio Strategies Group Llc who had been investing in Cvs Health for a number of months, seems to be less bullish one the $67.17B market cap company. The stock decreased 0.03% or $0.02 during the last trading session, reaching $66.08. About 5.64 million shares traded. CVS Health Corporation (NYSE:CVS) has declined 22.81% since April 17, 2017 and is downtrending. It has underperformed by 34.36% the S&P500.

Among 26 analysts covering CVS Health (NYSE:CVS), 19 have Buy rating, 0 Sell and 7 Hold. Therefore 73% are positive. CVS Health had 75 analyst reports since July 22, 2015 according to SRatingsIntel. Atlantic Securities downgraded the stock to “Neutral” rating in Monday, February 6 report. The rating was maintained by SunTrust with “Buy” on Thursday, January 4. The rating was maintained by Oppenheimer with “Outperform” on Monday, November 2. As per Wednesday, August 16, the company rating was maintained by Jefferies. Tigress Financial initiated the stock with “Buy” rating in Friday, April 28 report. Cowen & Co maintained CVS Health Corporation (NYSE:CVS) on Tuesday, June 13 with “Buy” rating. The stock of CVS Health Corporation (NYSE:CVS) earned “Buy” rating by UBS on Thursday, October 6. The rating was maintained by Citigroup with “Neutral” on Thursday, August 17. Citigroup maintained it with “Neutral” rating and $77 target in Tuesday, February 13 report. On Monday, September 25 the stock rating was maintained by Robert W. Baird with “Hold”.

Analysts await CVS Health Corporation (NYSE:CVS) to report earnings on May, 2 before the open. They expect $1.40 earnings per share, up 19.66% or $0.23 from last year’s $1.17 per share. CVS’s profit will be $1.42 billion for 11.80 P/E if the $1.40 EPS becomes a reality. After $1.92 actual earnings per share reported by CVS Health Corporation for the previous quarter, Wall Street now forecasts -27.08% negative EPS growth.

Investors sentiment decreased to 0.72 in Q4 2017. Its down 0.16, from 0.88 in 2017Q3. It dived, as 115 investors sold CVS shares while 600 reduced holdings. 134 funds opened positions while 380 raised stakes. 815.59 million shares or 1.76% more from 801.45 million shares in 2017Q3 were reported. Hsbc Hldgs Public Ltd Com holds 0.28% or 2.66M shares in its portfolio. Cubic Asset Lc has invested 1.51% in CVS Health Corporation (NYSE:CVS). E&G Advsr Lp reported 6,771 shares. Vanguard Group owns 78.58M shares. California State Teachers Retirement Sys has invested 0.29% in CVS Health Corporation (NYSE:CVS). 73,212 were reported by Nwq Investment Mgmt Limited. Pension Ser holds 0.31% of its portfolio in CVS Health Corporation (NYSE:CVS) for 850,361 shares. Compton Capital Inc Ri holds 29,871 shares. Ally, Michigan-based fund reported 90,000 shares. 5,500 are owned by Birinyi. Highland Mngmt Llc reported 45,841 shares. Magellan Asset Limited stated it has 0% of its portfolio in CVS Health Corporation (NYSE:CVS). Wolverine Asset Mngmt Limited Liability Corp reported 0% in CVS Health Corporation (NYSE:CVS). Reynders Mcveigh Mgmt Ltd Com invested 2.52% of its portfolio in CVS Health Corporation (NYSE:CVS). Stanley owns 0.45% invested in CVS Health Corporation (NYSE:CVS) for 28,485 shares.

Since February 16, 2018, it had 0 buys, and 1 sale for $1.42 million activity.

Princeton Portfolio Strategies Group Llc, which manages about $199.15 million and $366.75M US Long portfolio, upped its stake in Spdr Series Trust (SDY) by 5,217 shares to 8,388 shares, valued at $792,000 in 2017Q4, according to the filing. It also increased its holding in Westrock Co by 36,766 shares in the quarter, for a total of 46,766 shares, and has risen its stake in Ishares Tr (EFA).

Analysts await Tesla, Inc. (NASDAQ:TSLA) to report earnings on May, 2. They expect $-4.45 EPS, down 125.89% or $2.48 from last year’s $-1.97 per share. After $-3.84 actual EPS reported by Tesla, Inc. for the previous quarter, Wall Street now forecasts 15.89% negative EPS growth.

Since October 24, 2017, it had 0 insider purchases, and 10 insider sales for $4.46 million activity. On Tuesday, January 2 the insider Musk Kimbal sold $1.27M. FIELD JOHN DOUGLAS sold $476,944 worth of stock or 1,400 shares.

Investors sentiment decreased to 1.05 in 2017 Q4. Its down 0.25, from 1.3 in 2017Q3. It turned negative, as 105 investors sold TSLA shares while 156 reduced holdings. 69 funds opened positions while 206 raised stakes. 96.06 million shares or 3.01% more from 93.25 million shares in 2017Q3 were reported. Fisher Asset Management Ltd Liability Co has 1,085 shares for 0% of their portfolio. Catawba Cap Mngmt Va owns 2,935 shares or 0.21% of their US portfolio. Profund Advsrs Ltd Liability Co reported 0.13% in Tesla, Inc. (NASDAQ:TSLA). Winslow Evans & Crocker has 156 shares for 0.02% of their portfolio. Arrowgrass Prns (Us) Limited Partnership holds 0.2% in Tesla, Inc. (NASDAQ:TSLA) or 66,100 shares. Apriem Advisors, a California-based fund reported 3,423 shares. Hl Fincl Limited Liability Co holds 0.01% or 1,456 shares. Zevenbergen Capital Ltd Company owns 361,234 shares. Livforsakringsbolaget Skandia Omsesidigt, Sweden-based fund reported 2,031 shares. Ww Invsts holds 0.2% of its portfolio in Tesla, Inc. (NASDAQ:TSLA) for 3.03 million shares. Linscomb Williams has invested 0.17% of its portfolio in Tesla, Inc. (NASDAQ:TSLA). State Board Of Administration Of Florida Retirement System holds 185,551 shares. Ashfield Cap Prns Ltd Liability Corporation accumulated 2,690 shares. Moors & Cabot invested 0.12% in Tesla, Inc. (NASDAQ:TSLA). New York-based First Manhattan has invested 0% in Tesla, Inc. (NASDAQ:TSLA).

Among 36 analysts covering Tesla Motors Inc (NASDAQ:TSLA), 12 have Buy rating, 9 Sell and 15 Hold. Therefore 33% are positive. Tesla Motors Inc had 140 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was maintained by UBS on Friday, October 30 with “Sell”. The stock has “Buy” rating by Zacks on Tuesday, August 11. The stock has “Buy” rating by Dougherty & Company on Thursday, February 23. The rating was maintained by Robert W. Baird on Tuesday, June 20 with “Buy”. The firm has “Buy” rating by Guggenheim given on Friday, November 10. Evercore downgraded the shares of TSLA in report on Friday, October 27 to “In-Line” rating. As per Monday, July 10, the company rating was maintained by RBC Capital Markets. The stock has “Sell” rating by CFRA on Wednesday, November 1. Piper Jaffray maintained Tesla, Inc. (NASDAQ:TSLA) rating on Monday, October 16. Piper Jaffray has “Buy” rating and $386.0 target. As per Monday, December 14, the company rating was initiated by JMP Securities.

CVS Health Corporation (NYSE:CVS) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>